Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases

European Journal of Clinical Nutrition

Volumn 54, Issue 4, 2000, Pages 288-297

  Agerholm Larsen, L ^a   Raben, A ^a   Haulrik, N ^a   Hansen, A S ^a   Manders, M ^a   Astrup, A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Body weight; Cholesterol; Coagulation; Compliance; Fibrinolysis; Gut bacteria cultures

Indexed keywords

FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; BACTERIUM CULTURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS FAECIUM; FEMALE; FERMENTATION; HUMAN; IMMUNOSTIMULATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; MILK; MORPHOMETRICS; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STREPTOCOCCUS THERMOPHILUS; SYSTOLIC BLOOD PRESSURE;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FIBRINOGEN; HUMANS; INTESTINAL ABSORPTION; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PROBIOTICS; RISK FACTORS; YOGURT;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; STREPTOCOCCUS THERMOPHILUS;

EID: 0034032683     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600937     Document Type: Article

References (28)

1. Agerbæk M, Gerdes LU & Richelsen B (1995): Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur. J. Clin. Nutr. 49, 346-352.
2. Alles MS, Hautvast JGAJ, Nagengast FM, Hartemink R, Van Laere KMJ & Jansen JBMJ (1996): Fate of fructo-oligosaccharides in the human intestine. Br. J. Nutr. 76, 211-221.
3. Bertolami MC, Faludi AA & Batlouni M (1999): Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur. J. Clin. Nutr. 53, 97-101.
4. Burstein M, Scholnick HR & Morfin R (1970): Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11, 583-595.
5. Clauss A (1957): Gerinnungsphydiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat. 17, 237-246.
6. Friedewald WT, Levy RJ & Frederickson DS (1972): Estimation and the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin. Chem. 18, 499-509.
7. Gabay C & Kushner I (1999): Acute-phase proteins and other systemic responses to inflammation (review). New Engl. J. Med. 340 (6), 448-454.
8. Gilliland SE & Speck ML (1977): Deconjugation of bile acids by intestinal Lactobacilli. Appl. Environ. Microbiol. 33, 15-18.
9. Gilliland SE, Nelson CR & Maxwell C (1985): Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49, 377-381.
10. Grundy SM (1997): Small LDL, atherogenic dyslipidemia and the metabolic syndrome. Circulation 95, 1-4.
11. Havenaar R & Minekus M (1996): Simulated assimilation. Dairy Ind. Int. 61 (9).
12. 3) resistant starch on putative risk factors for colon cancer in healthy men. Am. J. Clin. Nutr. 67, 332-331.
13. Heinrich J, Balleisen L, Schulte H, Assmann G & van de Loo J (1994): Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler. Thromb. 14, 54-59.
14. Heitmann BL (1990): Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int. J. Obes. 14, 789-802.
15. Jespersen J & Sidelmann J (1982): A study of condition and accuracy of the thrombin time assay of plasma fibrinogen. Acta Haematol. 67, 2-7.
16. Kattermann R, Jaworek D, Moller G, Assmann G, Bjorkhem I, Svensson L, Borner K, Boerma G, Leijnse B, Desager JP et al (1984): Multicentre study of a new method of cholesterol determination. Clin. Chem. Clin. Biochem. 22, 245-251.
17. Klaver FAM & van der Meer R (1993): The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl. Environ. Metab. 59, 1120-1124.
18. Larsen LF, Bladbjerg E-M, Jespersen J & Marckman P (1997): Effects of dietary quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler. Thromb. Vasc. Biol. 17, 2904-2909.
19. Law MR & Wald NJ (1994): An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur. J. Clin. Nutr. 48, 305-325.
20. Lopes-Virella MF, Stone P, Ellis S & Colwell JA (1977): Clin. Chem. 23 (5), 882-884.
21. MD Foods Report (1998): Study regarding the relation between bile tolerance, deconjugation of bile salts and assimilation of cholesterol on a number of bacteria strains, by Kaalby A & Andersen H (unpublished).
22. Rånby M et al (1994): A Biofunctional Immunoassay, BIA, for Tissue Plasminogen Activator, TPA. Lieden Workshop on Fibrinolysis.
23. Richelsen B, Kristensen K & Pedersen SB (1996): Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins-a placebo-controlled and double blind study. Eur. J. Clin. Nutr. 50, 811-815.
24. Sanchez-Castillo CP, Branch WJ & James WPT (1987): A test of the validity of the lithium-marker technique for monitoring dietary sources of salt in man. Clin. Sci. 72, 87-94.
25. Seidel J, Hagele EO, Ziegenhorn J & Wahlefeld AW (1983): Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem. 29, 1075-1080.
26. Taranto MP, Gonzelez De Llano D, Rodriguez A, Pesce De Ruiz Holgado A & Font De Valdez G (1996): Bile tolerance and cholesterol reduction by Enterococcus faecium, a candidate microorganism for the use as a dietary adjunct in milk products. Milchwissenschaft 51(7), 383-385.
27. Wahlefeld AW (1974): Methods of Enzymatic Analysis, 2nd English edn. (Translated from 3rd German edn.), ed. Bergmeyer HU, pp 1831 ff. Weinheim: Verlag Chemie/New York: Academic Press.
28. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L & Tibblin G (1984): Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl. J. Med. 311, 501-505.